08:40 AM EDT, 03/16/2026 (MT Newswires) -- Martine A Rothblatt, Director, Chairperson and Chief Executive Officer, on March 12, 2026, sold 9,500 shares in United Therapeutics ( UTHR ) for $5,109,148. Following the Form 4 filing with the SEC, Rothblatt has control over a total of 639,489 common shares of the company, with 130 shares held directly and 639,359 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1082554/000110657826000010/xslF345X05/primarydocument.xml